InnovaBioPat LLC

About InnovaBioPat LLC

InnovaBioPat LLC is a life sciences IP strategy and patent prosecution practice focused on building high-value, defensible patent portfolios for innovative biotechnology and medical device companies. We work at the intersection of complex biology and commercial reality—translating cutting-edge science into strategically crafted patent assets that withstand scrutiny from competitors, investors, and regulators. Our expertise spans biologics, therapeutic antibodies, cell and gene therapies, diagnostics, and drug-device combinations, with particular strength in manufacturing and platform technologies, where IP strategy often determines long-term competitive advantage. Core capabilities include: U.S. and PCT patent preparation and prosecution Portfolio strategy aligned with R&D, clinical, and regulatory milestones Claim architecture designed for durability under evolving enablement and written description standards Freedom-to-operate risk assessment and design-around strategy IP support for partnering, diligence, and lifecycle management Founded by a former Senior Patent Agent at Genentech (Roche Group) and Thermo Fisher Scientific, InnovaBioPat brings top-tier in-house experience to clients who need sophisticated IP strategy without the inefficiency of traditional law firm models. The focus is simple: build patent portfolios that are not just broad—but credible, defensible, and aligned with how the science and the business will actually evolve.